
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies
Marc Emmenegger, Elena De Cecco, Marián Hruška-Plocháň, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 9
Open Access | Times Cited: 64
Marc Emmenegger, Elena De Cecco, Marián Hruška-Plocháň, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 9
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
LAG-3 as the third checkpoint inhibitor
Vaishali Aggarwal, Creg J. Workman, Dario A.A. Vignali
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1415-1422
Open Access | Times Cited: 160
Vaishali Aggarwal, Creg J. Workman, Dario A.A. Vignali
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1415-1422
Open Access | Times Cited: 160
Clinical landscape of LAG-3-targeted therapy
Luisa Chocarro, Ester Blanco, Hugo Arasanz, et al.
Immuno-Oncology Technology (2022) Vol. 14, pp. 100079-100079
Open Access | Times Cited: 73
Luisa Chocarro, Ester Blanco, Hugo Arasanz, et al.
Immuno-Oncology Technology (2022) Vol. 14, pp. 100079-100079
Open Access | Times Cited: 73
The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy
Roy A. Mariuzza, Salman Shahid, S.S. Karade
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107241-107241
Open Access | Times Cited: 25
Roy A. Mariuzza, Salman Shahid, S.S. Karade
Journal of Biological Chemistry (2024) Vol. 300, Iss. 5, pp. 107241-107241
Open Access | Times Cited: 25
Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 20
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 20
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Marián Hruška-Plocháň, Vera I. Wiersma, A Betz, et al.
Nature (2024) Vol. 626, Iss. 8001, pp. 1073-1083
Open Access | Times Cited: 17
Marián Hruška-Plocháň, Vera I. Wiersma, A Betz, et al.
Nature (2024) Vol. 626, Iss. 8001, pp. 1073-1083
Open Access | Times Cited: 17
Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease
Kaimin Wu, Qianhui Xu, Yi-Qi Liu, et al.
Science (2025) Vol. 387, Iss. 6736, pp. 892-900
Closed Access | Times Cited: 4
Kaimin Wu, Qianhui Xu, Yi-Qi Liu, et al.
Science (2025) Vol. 387, Iss. 6736, pp. 892-900
Closed Access | Times Cited: 4
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Grace m. Kuo, Ramhari Kumbhar, W. Frank Blair, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Grace m. Kuo, Ramhari Kumbhar, W. Frank Blair, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Initiation and progression of α-synuclein pathology in Parkinson’s disease
George K. Tofaris
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 69
George K. Tofaris
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 69
Non-specificity as the sticky problem in therapeutic antibody development
Hannes Ausserwöger, Matthias M. Schneider, Therese W. Herling, et al.
Nature Reviews Chemistry (2022) Vol. 6, Iss. 12, pp. 844-861
Closed Access | Times Cited: 53
Hannes Ausserwöger, Matthias M. Schneider, Therese W. Herling, et al.
Nature Reviews Chemistry (2022) Vol. 6, Iss. 12, pp. 844-861
Closed Access | Times Cited: 53
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 49
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 49
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 613-640
Open Access | Times Cited: 47
Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 613-640
Open Access | Times Cited: 47
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Autophagy in Parkinson’s Disease
Lior Nechushtai, Dan Frenkel, Ronit Pinkas‐Kramarski
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1435-1435
Open Access | Times Cited: 36
Lior Nechushtai, Dan Frenkel, Ronit Pinkas‐Kramarski
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1435-1435
Open Access | Times Cited: 36
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
Xiaobo Mao, Hao Gu, Donghoon Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Xiaobo Mao, Hao Gu, Donghoon Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity
Stephanie Burnell, Lorenzo Capitani, Bruce J. MacLachlan, et al.
Immunotherapy Advances (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 45
Stephanie Burnell, Lorenzo Capitani, Bruce J. MacLachlan, et al.
Immunotherapy Advances (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 45
Improving Cell Recovery: Freezing and Thawing Optimization of Induced Pluripotent Stem Cells
Markus Uhrig, Fernando Ezquer, Marcelo Ezquer
Cells (2022) Vol. 11, Iss. 5, pp. 799-799
Open Access | Times Cited: 30
Markus Uhrig, Fernando Ezquer, Marcelo Ezquer
Cells (2022) Vol. 11, Iss. 5, pp. 799-799
Open Access | Times Cited: 30
α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
Noah J. Graves, Yann Gambin, Emma Sierecki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12134-12134
Open Access | Times Cited: 18
Noah J. Graves, Yann Gambin, Emma Sierecki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12134-12134
Open Access | Times Cited: 18
Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: From biology to the clinic
Yaser E. Alqurashi
Pathology - Research and Practice (2024) Vol. 254, pp. 155124-155124
Closed Access | Times Cited: 7
Yaser E. Alqurashi
Pathology - Research and Practice (2024) Vol. 254, pp. 155124-155124
Closed Access | Times Cited: 7
The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
Yongzhen Miao, Hongrui Meng
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Yongzhen Miao, Hongrui Meng
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
Michael X. Henderson, Martin T. Henrich, Fanni F. Geibl, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105687-105687
Open Access | Times Cited: 26
Michael X. Henderson, Martin T. Henrich, Fanni F. Geibl, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105687-105687
Open Access | Times Cited: 26
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Sandesh Neupane, Elena De Cecco, Adriano Aguzzi
Journal of Molecular Biology (2022) Vol. 435, Iss. 12, pp. 167930-167930
Open Access | Times Cited: 25
Sandesh Neupane, Elena De Cecco, Adriano Aguzzi
Journal of Molecular Biology (2022) Vol. 435, Iss. 12, pp. 167930-167930
Open Access | Times Cited: 25
Disease modification in Parkinsonism: obstacles and ways forward
Matthias Höllerhage, Martin Klietz, Günter U. Höglinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1133-1153
Open Access | Times Cited: 23
Matthias Höllerhage, Martin Klietz, Günter U. Höglinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1133-1153
Open Access | Times Cited: 23
Microfluidic antibody affinity profiling of alloantibody-HLA interactions in human serum
Matthias M. Schneider, Tom Scheidt, Ashley J. Priddey, et al.
Biosensors and Bioelectronics (2023) Vol. 228, pp. 115196-115196
Open Access | Times Cited: 15
Matthias M. Schneider, Tom Scheidt, Ashley J. Priddey, et al.
Biosensors and Bioelectronics (2023) Vol. 228, pp. 115196-115196
Open Access | Times Cited: 15